References
References
1. Rippie E. (1990) Compression of solids and compressed dosage forms. In: Encyclopedia of Pharmaceutical Technology. Swarbrick J. (Eds) Marcel Dekker Inc. NY. Vol. 3. pp. 149-166.
2. Rudnic E. and Schwartz J. B. Oral solid dosage forms In: Remington’s Pharmaceutical Sciences. 18 th Ed. 1990. Ed. Gennaro, A. R. Mack Publishing Company. Easton , Pennsylvania , USA.pp. 1633-1665.
3. British Pharmacopoeia (1998) HMSO, London .
4. Seitz, J. A. and Flessland, G. M. (1965) Evaluation of physical properties of compressed tablets, 1: tablet hardness and friability. J. Pharm. Sci., 54: 1353-1357.
5. Upadrashta, S. M., Katikaneni, P. R. and Nuessla, N. O. (1992) Chitosan as a tablet binder. Drug Dev. Ind. Pharm., 18: 1701-1708.
6. Fell, J. T. and Newton , J. M. (1970) Determination of tablet strength by diametral - compression test. J. Pharm. Sci., 59: 688-691.
7. Odeku, O. A. and Itiola O. A. (2003) Evaluation of the effects of khaya gum on the mechanical and release properties of paracetamol tablet formulation. Drug Dev. Ind. Pharm. , 29, 311-320.
8. Odeku, O. A. (2005) Assessment of Albizia zygia gum as binding agent in tablet formulations. Acta Pharm . 55:263-276.
9. Odeku, O. A and Itiola O. A. (1998) Evaluation of khaya gum as a binder in a paracetamol tablet formulation . Pharm . Pharmacol Commun , 4: 183-188.
10. Newton , J. M., Rowley, G., Fell, J. T., Peacock, D. G. and Ridgway, K. (1971) Computer analysis of the relation between tablet strength and compaction pressure. J. Pharm. Pharmacol., 23: 195S-201S.
11. Down, G. R. B. and McMullen, J. M. (1985) The effect of interparticulate friction and moisture on the crushing strength of sodium chloride compact. Powder Technol., 42: 169-174.
12. Hiestand, E. N. and Smith, D. P. (1984) Indices of tabletting performance. Powder Technol., 38: 145-159.
13. David, S. T. and Augsburger, L. L. (1977) Plastic flow during compression of directly compressible fillers and its effect on tablet strength. J. Pharm. Sci., 66: 155-159.
14. Jarosz, P. J. and Parrott, E. L. (1982) Factors influencing axial and radial tensile strengths of tablets J. Pharm. Sci., 71: 607 - 401.
15. Leuenberger, H. and Rohera, B. D. (1986) Fundamental properties of powder compression I. The compactibility and compressibility of pharmaceutical powders. Pharm. Res., 3: 12-22.
16. Celik, M. (1992) Overview of compaction data analysis techniques. Drug Dev. Ind. Pharm., 18: 767-810.
17. Hiestand, E. N., Wells, J. E., Poet, C. B. and Ochs, J. F. (1977) Physical processes of tabletting. J. Pharm. Sci. 66: 510 - 519.
18. Hiestand, E. N. Rationale for and the measurements of tableting indices. In: Pharmaceutical Powder Compaction Technology, Alderborn, G., Nystrom, C (Eds.) Marcel Dekker , New York , 1996, pp. 219-244.
19. Durelli, A. J. Lin, Y. H. (1986) Stress and displacements on boundaries of circular rings diametrically loaded. J. Appl. Mech. 53: 213-219.
20. Podzeck, F and Newton , J. M. (2003) The implications of the determination of the mechanical strength of powder compacts containing a pre-formed hole. Powder Technol. 132: 10-15.
21. Itiola, O. A. and Pilpel, N. ( 1986a ) Tabletting characteristics of metronidazole formulations. Int. J. Pharm. 31: 99-105.
22. Roberts, R. J. and Rowe, R. C. (1986) The effect of the relationship between punch velocity and particle size on the compaction behaviour of materials with varying deformation mechanisms. J. Pharm. Pharmacol. , 38: 566-571.
23. Itiola, O. A. (1991) Compressional characteristics of three starches and the mechanical properties of their tablets. Pharm. World J., 8(3) : 91-94.
24. Odeku, O. A. Awe, O. O. Popoola, B. Odeniyi, M. A. and Itiola, O. A. (2005) Compression and mechanical properties of tablet formulations containing corn, sweet potato, and cocoyam starches as binders. Pharm Tech 29 (4): 82-90.
25. Odeku, O. A. and Patani, B. O. (2005) Evaluation of dika nut mucilage ( Irvingia gabonensis ) as a binder in metronidazole tablet formulations. Pharm . Dev . Tech . 10: 439-446.
26. Banker, G. S. and Anderson, N. R., Tablets. In : The Theory and Practice of Industrial Pharmacy. Lachman, L., Lieberman, H. A. and Kanig, J. L. (Eds.) 3 rd Edition. (1986) Lea & Febiger, Philadelphia , pp. 301-303.
27. Guyot-Hermann; (1992) The disintegration and disintegrating agent; S.T.P. Pharmaceutical Science: 2(6): 445-462.
28. Matsumaru, H. (1959) Mechanism of tablet compression and disintegration, IV. Evolution of wetting heat and its relation to compressional force. Yakugaku Zasshi, 79: 63-64.
29. Lowenthal, W. (1973) Mechanisms of action of tablet disintegrants. Pharm. Acta. Helv., 48: 589-609.
30. Ringard, J. and Guyot-Hermann, A. M. (1981) Disintegration mechanisms of tablets containing starches: Hypothesis about the particle-particle repulsive forces. Drug Dev. Ind. Pharm., 7: 155-177.
31. Kanig, J. L. and Rudnic, C. (1984) The mechanisms of disintegrant action. Pharm. Technol., 8: 50-62.
32. Shangraw, R., Mitrevej, A. and Shah, M. (1980) New era of tablet disintegrants. Powder Technol., 4: 49-57.
33. Singh, P., Desai, S. J., Simonelli, A. P. and Higuchi, W. I. (1968) Role of wetting on the rate of drug release from inert matrices. J. Pharm. Sci., 57: 217-226.
34. Ganderton, D. (1969) The effect of distribution of magnesium stearate on the penetration of a tablet by water J. Pharm. Pharmacol., 21(suppl.): 9S - 18S.
35. Kurup, T. R. R. and Pilpel, N. (1977) The tensile strength and disintegration of griseofulvin tablets. Powder Technol., 16: 843-847.
36. Ganderton, D. and Shotton, E. (1961) The strength of compressed tablet. III. The relation of particle size, bonding and capping of sodium chloride, aspirin and hexamine. J. Pharm. Pharmacol., 12: 144T-152T.
37. Nogami, H., Hagai, T., Fukuola, E. and Sonobe, T. (1969) Disintegration of aspirin tablets containing potato starch and microcrystalline cellulose in various concentrations. Chem. Pharm. Bull., 17(7) : 1450-1455.
38. Amidon, G.L., Lennernas, H. Shah, V.P. Crison, J.R. (1995) A Theoretical Basis for a Biopharmaceutical Drug Classification: The Correlation of In Vitro Drug Product Dissolution and In Vivo Bioavailability, Pharm Res , 12:413-420.
39. Levy, G (1961) Comparison of dissolution and absorption rates of different commercial aspirin tablets. J. Pharm. Sci., 50: 388-392.
40. Itiola, O. A. and Pilpel, N. (1986) Studies on metronidazole tablet formulations. J. Pharm. Pharmacol. 38: 81-86.
41. Itiola, O. A. and Pilpel, N. (1996) Effects of interacting variables on the disintegration and dissolution of metronidazole tablets. Pharmazie . 51: 997-998.
42. Odeku, O. A. and Itiola, O. A. (2003) Effects of interacting variables on the tensile strength and release properties of paracetamol tablet. Trop. J. Pharm. Res . 2 (1): 147-153.
43. Florence , A. T. and Halbert, G. W. (1990) Formulation. In: Comparative medicinal chemistry: The rational design, mechanistic study and therapeutic application of chemical compound. Hansch, C., Sammes, P. G. and Taylor, J. B. (Eds) Vol. 6. 1 st Edition. Pergamon Press Plc. Oxford , UK . pp. 567-592.
44. Siewert, M., Dressman, J., Brown, C. K. and Shah, V. P. (2003) FIP/AAPS Guidelines to Dissolution/ in vitro release testing of novel/special dosage forms. AAPS PharmSciTech 4 (1) Article 7 ( www.pharmscitech.org).
45. Levy, G., Leonards, J. R. and Procknel, J. A. (1965) Development of in-vitro dissolution tests which correlate quantitatively with dissolution rate limited drug absorption in man. J. Pharm. Sci., 54: 1719-1722.
46. Levy, G. and Miller, K. E. (1964) Determination of drug absorption rates without chemical assay. J. Pharm. Sci., 53: 1301-1305.
47. Odeku, O. A. and Itiola, O. A. (2005) Advances in dissolution test in pharmaceutical analysis.
48. Wurster, D. E. and Taylor, P. W. (1965) Dissolution rates. J. Pharm. Sci., 54: 169-175.
49. Swabrick, J. and Ma, D. (1981) In vitro dissolution of dapsone. J. Pharm. Pharmacol., 31: 787 - 789.
50. Higuchi, W. I. (1967) Diffusional models useful in biopharmaceutics drug release rate processes. J. Pharm. Sci., 56: 315-324.
51. Noyes, A. A. and Whitney, W. R. (1897) The rate of solution of solid substances in their own solutions. J. Am. Chem. Soc., 19: 930-934.
52. Aguiar, A. J., Krc, J., Kinkel, A. W. and Samyn, J. C. (1967) Effect of polymorphism on the absorption of chloramphenicol palmitate. J. Pharm. Sci., 56: 847-853.
53. Wagner, J. G. (1969) Interpretation of percent dissolved-time plots derived from in-vitro testing of conventional tablets and capsules. J. Pharm. Sci., 58: 1253-1257.
54. Kitazawa, S., Johno, I. , Ito, Y., Teramura, S. and Okada, J. (1975) Effects of hardness on the disintegration time and the dissolution rate of uncoated caffeine tablets. J. Pharm. Pharmacol., 27: 765-770.
55. Kitazawa, S., Johno, I. , Minouchi, T. and Okada, J. (1977) Interpretation of dissolution rate data from in-vitro testing of compressed tablets. J. Pharm. Pharmacol., 29: 453 - 459.
